abstract |
Novel heterocyclic compounds of the formula I n nin which R 1 , R 2 , R 2′ , R 2″ , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 have the meanings indicated in Claim 1, n nare activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy. |